Literature DB >> 25445490

Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Wynne Q Zhang1, Corey M Smolik2, Priscilla A Barba-Escobedo3, Monica Gamez4, Jesus J Sanchez2, Martin A Javors2, Lynette C Daws2, Georgianna G Gould5.   

Abstract

Clinical evidence indicates brain serotonin (5-HT) stores and neurotransmission may be inadequate in subpopulations of individuals with autism, and this may contribute to characteristically impaired social behaviors. Findings that depletion of the 5-HT precursor tryptophan (TRP) worsens autism symptoms support this hypothesis. Yet dietetic studies show and parents report that many children with autism consume less TRP than peers. To measure the impact of dietary TRP content on social behavior, we administered either diets devoid of TRP, with standard TRP (0.2 g%), or with 1% added TRP (1.2 g%) overnight to three mouse strains. Of these, BTBRT(+)Itpr3(tf)/J and 129S1/SvImJ consistently exhibit low preference for social interaction relative to C57BL/6. We found that TRP depletion reduced C57BL/6 and 129S social interaction preference, while TRP enhancement improved BTBR sociability (p < 0.05; N = 8-10). Subsequent marble burying did not differ among diets or strains. After behavior tests, brain TRP levels and plasma corticosterone were higher in TRP enhanced C57BL/6 and BTBR, while 5-HT levels were reduced in all strains by TRP depletion (p < 0.05; N = 4-10). Relative hyperactivity of BTBR and hypoactivity of 129S, evident in self-grooming and chamber entries during sociability tests, were uninfluenced by dietary TRP. Our findings demonstrate mouse sociability and brain 5-HT turnover are reduced by acute TRP depletion, and can be enhanced by TRP supplementation. This outcome warrants further basic and clinical studies employing biomarker combinations such as TRP metabolism and 5-HT regulated hormones to characterize conditions wherein TRP supplementation may best ameliorate sociability deficits.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  129S1/SvImJ; Autism; BTBR; C57BL/6; Grooming; Marble burying; Serotonin; Social behavior; Tryptophan

Mesh:

Substances:

Year:  2014        PMID: 25445490      PMCID: PMC4276517          DOI: 10.1016/j.neuropharm.2014.10.024

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  89 in total

1.  Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies.

Authors:  Georgianne L Arnold; Susan L Hyman; Robert A Mooney; Russell S Kirby
Journal:  J Autism Dev Disord       Date:  2003-08

2.  Candidate gene associations with withdrawn behavior.

Authors:  David H Rubin; Robert R Althoff; Erik A Ehli; Gareth E Davies; David C Rettew; Eileen T Crehan; John T Walkup; James J Hudziak
Journal:  J Child Psychol Psychiatry       Date:  2013-06-28       Impact factor: 8.982

Review 3.  Elimination diets in autism spectrum disorders: any wheat amidst the chaff?

Authors:  George W Christison; Kristin Ivany
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

Review 4.  Behavioural phenotyping assays for mouse models of autism.

Authors:  Jill L Silverman; Mu Yang; Catherine Lord; Jacqueline N Crawley
Journal:  Nat Rev Neurosci       Date:  2010-07       Impact factor: 34.870

5.  Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Simone Tambaro; Felix G Li; Paola Devoto; Marcelo P Coba; Kevin Chen; Jean C Shih
Journal:  Neuropharmacology       Date:  2013-07-16       Impact factor: 5.250

Review 6.  Drug therapy in autism: a present and future perspective.

Authors:  Baldeep Kumar; Ajay Prakash; Rakesh K Sewal; Bikash Medhi; Manish Modi
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

7.  Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice.

Authors:  Nicole L Baganz; Rebecca E Horton; Alfredo S Calderon; W Anthony Owens; Jaclyn L Munn; Lora T Watts; Nina Koldzic-Zivanovic; Nathaniel A Jeske; Wouter Koek; Glenn M Toney; Lynette C Daws
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

8.  Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.

Authors:  Marguerite C Camp; Kathryn P Macpherson; Lauren Lederle; Carolyn Graybeal; Stefano Gaburro; Lauren M Debrouse; Jessica L Ihne; Javier A Bravo; Richard M O'Connor; Stephane Ciocchi; Cara L Wellman; Andreas Lüthi; John F Cryan; Nicolas Singewald; Andrew Holmes
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

9.  Decreased tryptophan metabolism in patients with autism spectrum disorders.

Authors:  Luigi Boccuto; Chin-Fu Chen; Ayla R Pittman; Cindy D Skinner; Heather J McCartney; Kelly Jones; Barry R Bochner; Roger E Stevenson; Charles E Schwartz
Journal:  Mol Autism       Date:  2013-06-03       Impact factor: 7.509

10.  Origin of the blood hyperserotonemia of autism.

Authors:  Skirmantas Janusonis
Journal:  Theor Biol Med Model       Date:  2008-05-22       Impact factor: 2.432

View more
  25 in total

1.  Cell-Type-Specific Modulation of Sensory Responses in Olfactory Bulb Circuits by Serotonergic Projections from the Raphe Nuclei.

Authors:  Daniela Brunert; Yusuke Tsuno; Markus Rothermel; Michael T Shipley; Matt Wachowiak
Journal:  J Neurosci       Date:  2016-06-22       Impact factor: 6.167

Review 2.  Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Mu Yang; Jill L Silverman; Marjorie Solomon; Jacqueline N Crawley
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 3.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

Review 4.  The BTBR mouse model of idiopathic autism - Current view on mechanisms.

Authors:  K Z Meyza; D C Blanchard
Journal:  Neurosci Biobehav Rev       Date:  2017-02-03       Impact factor: 8.989

5.  Mapping the living mouse brain neural architecture: strain-specific patterns of brain structural and functional connectivity.

Authors:  Meltem Karatas; Vincent Noblet; Md Taufiq Nasseef; Thomas Bienert; Marco Reisert; Jürgen Hennig; Ipek Yalcin; Brigitte Lina Kieffer; Dominik von Elverfeldt; Laura-Adela Harsan
Journal:  Brain Struct Funct       Date:  2021-02-26       Impact factor: 3.270

6.  Examining the Reversibility of Long-Term Behavioral Disruptions in Progeny of Maternal SSRI Exposure.

Authors:  Susan E Maloney; Shyam Akula; Michael A Rieger; Katherine B McCullough; Krystal Chandler; Adrian M Corbett; Audrey E McGowin; Joseph D Dougherty
Journal:  eNeuro       Date:  2018-07-09

7.  Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.

Authors:  Kristen R Trexler; Sara R Nass; Molly S Crowe; Joshua D Gross; Margaret S Jones; Austin W McKitrick; David P Siderovski; Steven G Kinsey
Journal:  Drug Alcohol Depend       Date:  2018-07-07       Impact factor: 4.492

Review 8.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

9.  Nutritional status and social behavior in preschool children: the mediating effects of neurocognitive functioning.

Authors:  Jianghong Liu; Adrian Raine
Journal:  Matern Child Nutr       Date:  2016-05-01       Impact factor: 3.092

Review 10.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.